These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 23773640)

  • 41. Procalcitonin levels predicting the infliximab response of immunoglobulin resistant Kawasaki disease.
    Nakashima Y; Nanishi E; Yamamura K; Uike K; Terashi E; Hirata Y; Nagata H; Morihana E; Tanaka T; Honjo S; Takada H; Ohga S
    Cytokine; 2019 Feb; 114():26-31. PubMed ID: 30583086
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vital Signs as Predictor Factors of Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease.
    Gámez-González LB; Hamada H; Cisneros Castolo M; Honda T; Yasukawa K; Takanashi JI
    Clin Pediatr (Phila); 2018 Sep; 57(10):1148-1153. PubMed ID: 29486579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E; Ertugrul I; Bilginer Y; Batu ED; Sonmez HE; Demir S; Arici ZS; Sag E; Alehan D; Ozen S
    Rheumatol Int; 2019 Aug; 39(8):1343-1349. PubMed ID: 31139951
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model.
    Zhou Y; Wu Y; Yuan C; Yin W; Wang B; Ding Y
    BMC Pediatr; 2023 Dec; 23(1):642. PubMed ID: 38114939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
    Yanagimoto K; Nomura Y; Masuda K; Hirabayashi M; Morita Y; Yoshishige M; Ueno K; Eguchi T; Kawano Y
    Int Arch Allergy Immunol; 2014; 164(2):83-8. PubMed ID: 24903098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to intravenous immunoglobulin (IVIG) in Kawasaki disease: no influence of different IVIG lot utilisation.
    Pagnini I; Marino A; Simonini G; Cimaz R
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S170. PubMed ID: 22410254
    [No Abstract]   [Full Text] [Related]  

  • 49. [Values of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in predicting sensitivity to intravenous immunoglobulin in Kawasaki disease].
    Yuan YD; Sun J; Li PF; Wei CL; Yu YH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Apr; 19(4):410-413. PubMed ID: 28407827
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients.
    Zhang R; Shuai S; Zhang H; Cai J; Cui N; Tang M; Xing S; Gao Y; Liu X; Yang X
    Ital J Pediatr; 2023 Jun; 49(1):78. PubMed ID: 37357258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR; Zhao HZ; Chang LJ; Xu X; Gao Y; Li M; Kong QY; Wang MM; Zhao CF
    Eur J Pediatr; 2023 Oct; 182(10):4399-4406. PubMed ID: 37480545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
    Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Value of C-reactive protein/albumin ratio in predicting intravenous immunoglobulin-resistant Kawasaki disease- a data from multi-institutional study in China.
    Li G; Wang T; Gou Y; Zeng R; Liu D; Duan Y; Liu B
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107037. PubMed ID: 33242833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.
    Chen CJ; Huang FC; Tiao MM; Huang YH; Lin LY; Yu HR; Yang KD; Huang YC; Chen CC; Chang WC; Kuo HC
    ScientificWorldJournal; 2012; 2012():485758. PubMed ID: 22792043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.
    Doi M; Takeda T; Sakurai Y; Kato J; Hayashi T; Fukuda K; Takase T; Shima M
    J Investig Allergol Clin Immunol; 2010; 20(5):413-8. PubMed ID: 20945608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease.
    Lee KY; Lee HS; Hong JH; Han JW; Lee JS; Whang KT
    J Trop Pediatr; 2005 Apr; 51(2):98-101. PubMed ID: 15677370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High neutrophil : lymphocyte ratio is associated with refractory Kawasaki disease.
    Cho HJ; Bak SY; Kim SY; Yoo R; Baek HS; Yang S; Hwang IT; Ban JE
    Pediatr Int; 2017 Jun; 59(6):669-674. PubMed ID: 28097746
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
    Ge X; Li CR; Yang J; Wang GB
    Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P; Hong-Hgam C; Khositseth A; Wanitkun S
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.